Literature DB >> 22561204

Pig lenses in a lens stretcher: implications for presbyopia treatment.

Robert Kammel1, Roland Ackermann, Torsten Mai, Christoph Damm, Stefan Nolte.   

Abstract

PURPOSE: To investigate porcine lenses in a lens stretcher with regard to presbyopia corrective procedures.
METHODS: A lens stretching device was designed, which allows to simultaneously determine all relevant geometrical and optical parameters at each stretch position. The setup was used to compare the optical and geometrical lens properties of young slaughter pigs (n = 5) with older sows (n = 7).
RESULTS: The change of optical power with stretching is about five times larger for young porcine lenses than for sows. For young pigs, the gradient index profile of the crystalline lens significantly contributes to the induced accommodation amplitude.
CONCLUSIONS: We have shown that sow lenses are a suitable model for in vitro experiments on possible treatments for presbyopia. The rapid decrease in the induced accommodation amplitude with age may be explained by a reduced change of all geometrical lens parameters, which in turn leads to a smaller contribution of the gradient index profile to accommodation.

Entities:  

Mesh:

Year:  2012        PMID: 22561204     DOI: 10.1097/OPX.0b013e318255da87

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  3 in total

1.  Simulating the Mechanics of Lens Accommodation via a Manual Lens Stretcher.

Authors:  Joshua N Webb; Caroline Dong; Andres Bernal; Giuliano Scarcelli
Journal:  J Vis Exp       Date:  2018-02-23       Impact factor: 1.355

2.  Pharmacologically stimulated pupil and accommodative changes in Guinea pigs.

Authors:  Lisa A Ostrin; Mariana B Garcia; Vivian Choh; Christine F Wildsoet
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-05       Impact factor: 4.799

3.  Lens Stretching Modulates Lens Epithelial Cell Proliferation via YAP Regulation.

Authors:  Bharat Kumar; Heather L Chandler; Timothy Plageman; Matthew A Reilly
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-09-03       Impact factor: 4.799

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.